These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 178940)

  • 1. Further studies of specificity of antibodies contained in antiserum against poliovirus.
    Urasawa S; Urasawa T; Kanamitsu M
    Jpn J Microbiol; 1976 Feb; 20(1):11-6. PubMed ID: 178940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variation of poliovirus caused by antibody components with different specificities.
    Urasawa S; Ishizawa F; Urasawa T
    Microbiol Immunol; 1977; 21(6):299-307. PubMed ID: 198635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of naturally occurring poliovirus-reactive immunoglobulins in bovine and equine sera.
    Urasawa S; Urasawa T; Ishizawa F; Taniguchi K
    Jpn J Med Sci Biol; 1987 Apr; 40(2):61-74. PubMed ID: 2828725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of escape mutants of a hybrid poliovirus with the aid of insert-specific polyclonal antibodies.
    Hovi T; Huovilainen A; Murdin A; Wimmer E
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1861-5. PubMed ID: 9049393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
    Lee CN; Kao CL; Lee CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
    Gaudin OG; Viac J; Thouvenot D; Sohier R
    Bull World Health Organ; 1974; 50(6):479-5. PubMed ID: 4376464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repertoire of antibodies against type 1 poliovirus in human sera.
    Rezapkin G; Neverov A; Cherkasova E; Vidor E; Sarafanov A; Kouiavskaia D; Dragunsky E; Chumakov K
    J Virol Methods; 2010 Nov; 169(2):322-31. PubMed ID: 20691212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis.
    Wiegers KJ; Dernick R
    J Gen Virol; 1985 May; 66 ( Pt 5)():1037-44. PubMed ID: 2582079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
    Glikmann G; Moynihan M; Petersen I; Vestergaard BF
    Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic variation of poliovirus studied by means of monoclonal antibodies.
    Crainic R; Blondel B; Horaud F
    Rev Infect Dis; 1984; 6 Suppl 2():S535-9. PubMed ID: 6204369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antigenic structure of poliovirus.
    Hogle JM; Filman DJ
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):467-78. PubMed ID: 2569204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.